猴痘检测市场 - 按技术（聚合酶炼式反应、侧流分析）、模式（实验室检测、护理点检测）、最终用途（医院和诊所、诊断实验室） - 全球预测（2024 - 2032）

Monkeypox Testing Market - By Technology (Polymerase Chain Reaction, Lateral Flow Assay), Mode (Laboratory Testing, Point of Care Testing), End-use (Hospitals and Clinics, Diagnostic Laboratories) - Global Forecast (2024 - 2032)

出版日期: 2024年05月24日 | 出版商:

Global Market Insights Inc. | 英文 125 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于猴痘爆发发生率不断增加，猴痘检测市场在 2024 年和 2032 年期间将录得 4.5% 的复合年增长率。 2024 年 5 月，世卫组织报告了 26 个国家新增 646 例实验室确诊猴痘病例，其中 15 例死亡。最近，多个地区猴痘病例再次出现，包括以前被认为是低风险的地区。这凸显了迫切需要有效、及时的诊断解决方案来管理和控制疫情，从而增加了对检测试剂盒的需求。

各国政府、医疗保健组织和公共卫生当局正在优先考虑制定和实施管理和控制包括猴痘在内的传染病的综合策略。这种高度关注是由于对有效监测和回应机制的日益增长的需求所推动的。对医疗保健基础设施的投资、增强的诊断能力以及建立健全的疾病管理协议都有助于产业的成长。

猴痘检测产业根据技术、模式、最终用途和地区进行分类。

聚合酶炼式反应领域将在 2032 年获得关注，因为 PCR 是一种高度灵敏且特异的方法，用于检测猴痘病毒的遗传物质，从而实现早期、准确的诊断。此技术能够扩增微量病毒 DNA，使其成为诊断猴痘感染不可或缺的工具。基于 PCR 的检测因其高精度和可靠性而受到青睐，这对于有效的疾病管理和控制至关重要。

诊断实验室市场份额将在 2024 年和 2032 年期间稳步增长，因为这些实验室负责进行猴痘测试并向医疗保健提供者提供准确的结果。越来越多配备先进检测技术的诊断实验室正在推动对猴痘检测解决方案的需求。此外，医疗设施的扩张和对传染病管理的日益关注也导致对猴痘检测服务的需求增加。

由于人们对先进诊断技术的认识和实施不断提高，到 2032 年，亚太地区猴痘检测产业将快速扩张。该地区国家正在加强医疗基础设施，并投资最先进的检测设施，以对抗传染病。人们对猴痘的认识不断提高，需要及早发现以正确治疗疾病。此外，地方政府和卫生组织正在优先考虑疾病监测和疫情管理，进一步增加了对猴痘检测解决方案的需求。

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Abbott Laboratories
Aegis Sciences Corporation
Applied DNA Sciences, Inc.
Becton, Dickinson and Company
BioGX
bioMerieux SA
Bio-Rad Laboratories, Inc.
CerTest Biotec
Creative Biogene
Danaher Corporation
Flow Health
Laboratory Corporation of America Holdings
Mayo Clinic Laboratories
Quest Diagnostics, Inc.
Thermo Fisher Scientific Inc.

简介目录

Product Code: 9634

The Monkeypox Testing Market will record 4.5% CAGR during 2024 and 2032, driven by the increasing incidences of monkeypox outbreaks. In May 2024, WHO reported 646 new laboratory-confirmed cases of monkeypox and 15 deaths across 26 countries. Lately, there has been a resurgence of monkeypox cases in various regions, including areas previously considered low risk. This has underscored the urgent need for effective and timely diagnostic solutions to manage and control outbreaks, boosting the demand for testing kits.

Governments, healthcare organizations, and public health authorities are prioritizing the development and implementation of comprehensive strategies to manage and control infectious diseases, including monkeypox. This heightened focus is driven by the growing need for effective surveillance and response mechanisms. Investments in healthcare infrastructure, enhanced diagnostic capabilities, and the establishment of robust disease management protocols are all contributing to the industry growth.

The monkeypox testing industry is classified based on technology, mode, end-use, and region.

The Polymerase Chain Reaction segment will gain traction through 2032, as PCR is a highly sensitive and specific method used to detect the genetic material of the monkeypox virus, enabling early and accurate diagnosis. The technology's ability to amplify minute quantities of viral DNA makes it an indispensable tool in diagnosing monkeypox infections. PCR-based tests are preferred for their high accuracy and reliability, which are crucial for effective disease management and control.

Diagnostic laboratories segment share will grow steadily during 2024 and 2032, as these laboratories are responsible for conducting monkeypox tests and providing accurate results to healthcare providers. The increasing number of diagnostic laboratories equipped with advanced testing technologies is driving the demand for monkeypox testing solutions. Additionally, the expansion of medical facilities and the growing focus on infectious disease management are contributing to the rise in demand for monkeypox testing services.

Asia Pacific monkeypox testing industry will expand at a fast pace through 2032, due to the increasing awareness and implementation of advanced diagnostic technologies. Countries in the region are enhancing their healthcare infrastructure and investing in state-of-the-art testing facilities to combat infectious diseases. There is rising awareness about monkeypox and need for early detection for proper management of the disease. Additionally, regional governments and health organizations are prioritizing disease surveillance and outbreak management, further boosting the demand for monkeypox testing solutions.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of monkeypox cases
  - 3.2.1.2 Increasing awareness among the population
  - 3.2.1.3 Advancements in diagnostic research
  - 3.2.1.4 Rising government funding and initiatives
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of testing
  - 3.2.2.2 Stringent regulatory challenges
3.3 Technological landscape
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Polymerase chain reaction (PCR)
5.3 Lateral flow assay (LFA)
5.4 Other technologies

Chapter 6 Market Estimates and Forecast, By Mode, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Laboratory testing
6.3 Point of care testing

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals and clinics
7.3 Diagnostic laboratories
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa